Amicus Therapeutics
   
contact us sitemap
 
 

Press Releases

= Add Release to Briefcase
All Releases
View Summary Amicus Therapeutics Announces First Quarter 2012 Financial Results
May 10, 2012
PDF 31.3 KB Add to Briefcase
View Summary Amicus Therapeutics to Announce First Quarter 2012 Financial Results on May 10, 2012
May 4, 2012
PDF 8.7 KB Add to Briefcase
View Summary Amicus Therapeutics Names William D. Baird, III Chief Financial Officer
Apr 16, 2012
PDF 8.8 KB Add to Briefcase
View Summary Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock and Exercise of Over-Allotment Option
Mar 7, 2012
PDF 10.1 KB Add to Briefcase
View Summary Amicus Therapeutics Prices Underwritten Offering of Common Stock
Mar 1, 2012
PDF 9.3 KB Add to Briefcase
View Summary Amicus Therapeutics Announces Proposed Public Offering of Common Stock
Mar 1, 2012
PDF 9.3 KB Add to Briefcase
View Summary Amicus Therapeutics to Present at 2012 RBC Global Healthcare Conference
Feb 28, 2012
PDF 8.1 KB Add to Briefcase
View Summary Amicus Therapeutics Announces Fourth Quarter and Full-Year 2011 Financial Results
Feb 13, 2012
PDF 30.4 KB Add to Briefcase
View Summary Amicus Therapeutics Presents Patient Screening Profiles From Phase 3 Fabry Study
Feb 13, 2012
PDF 15.1 KB Add to Briefcase
View Summary Amicus Therapeutics to Present at Leerink Swann 2012 Global Healthcare Conference
Feb 10, 2012
PDF 8.1 KB Add to Briefcase
View Summary Amicus Therapeutics Presents Preclinical Studies of Chaperone AT3375 for Gaucher Disease
Feb 9, 2012
PDF 13.1 KB Add to Briefcase
View Summary Amicus Therapeutics to Announce Fourth Quarter and Full-Year 2011 Financial Results on February 13, 2012
Feb 8, 2012
PDF 8.8 KB Add to Briefcase
View Summary Amicus Therapeutics Awarded Grant From Muscular Dystrophy Association for Pompe Disease Program
Feb 7, 2012
PDF 13.9 KB Add to Briefcase
View Summary Amicus Therapeutics Announces Posters and Presentations at Lysosomal Disease Network WORLD Symposium
Jan 30, 2012
PDF 13.6 KB Add to Briefcase
View Summary Amicus Therapeutics Appoints Bradley L. Campbell as Chief Business Officer
Jan 23, 2012
PDF 8.6 KB Add to Briefcase
View Summary Amicus Therapeutics Provides Full-Year 2012 Strategic Outlook and Financial Guidance
Jan 9, 2012
PDF 19.6 KB Add to Briefcase
View Summary Amicus Therapeutics Announces Positive Preliminary Results From Ongoing Phase 2 Chaperone-Enzyme Replacement Therapy (ERT) Study for Fabry Disease
Jan 6, 2012
PDF 16.5 KB Add to Briefcase
View Summary Amicus Therapeutics to Present at 30th Annual J.P. Morgan Healthcare Conference
Dec 22, 2011
PDF 10.1 KB Add to Briefcase
View Summary Amicus Therapeutics Completes Enrollment of 67 Patients in Phase 3 Study of Migalastat HCl for Fabry Disease
Dec 19, 2011
PDF 15.0 KB Add to Briefcase
View Summary Amicus Therapeutics Announces First Patient in Phase 2 Study for Pompe Disease
Dec 1, 2011
PDF 15.0 KB Add to Briefcase
Showing 1-20 of 147 releases Page: 1 2 3 4 5 6 7 8  See Next 20